Kate D. Lynch

536 total citations
23 papers, 123 citations indexed

About

Kate D. Lynch is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, Kate D. Lynch has authored 23 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Hepatology and 10 papers in Genetics. Recurrent topics in Kate D. Lynch's work include Inflammatory Bowel Disease (10 papers), Liver Diseases and Immunity (10 papers) and Microscopic Colitis (8 papers). Kate D. Lynch is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Liver Diseases and Immunity (10 papers) and Microscopic Colitis (8 papers). Kate D. Lynch collaborates with scholars based in Australia, United Kingdom and New Zealand. Kate D. Lynch's co-authors include Roger W. Chapman, Satish Keshav, Robert V. Bryant, Jane M. Andrews, Samuel P. Costello, Charlotte Goess, Emmanuel Selvaraj, Alessandra Geremia, Fay Probert and Daniel Radford‐Smith and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Kate D. Lynch

15 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate D. Lynch Australia 5 70 56 34 34 18 23 123
Waleed Fateen United Kingdom 7 98 1.4× 84 1.5× 38 1.1× 18 0.5× 15 0.8× 12 172
Stefan Lueth Germany 4 84 1.2× 83 1.5× 18 0.5× 14 0.4× 17 0.9× 7 187
Rika Iwata Switzerland 5 110 1.6× 78 1.4× 24 0.7× 28 0.8× 7 0.4× 6 173
Álvaro Giráldez Gallego Spain 7 67 1.0× 47 0.8× 33 1.0× 15 0.4× 20 1.1× 33 154
Kai‐Chi Chang Taiwan 10 113 1.6× 112 2.0× 43 1.3× 9 0.3× 16 0.9× 30 195
Martina Gagliardi Italy 7 53 0.8× 42 0.8× 22 0.6× 18 0.5× 74 4.1× 9 179
Chengxiao Yu China 9 155 2.2× 78 1.4× 28 0.8× 35 1.0× 41 2.3× 28 242
Michaela Neagu Germany 3 40 0.6× 48 0.9× 31 0.9× 37 1.1× 7 0.4× 3 131
Rebecca Saich United Kingdom 5 79 1.1× 106 1.9× 65 1.9× 17 0.5× 13 0.7× 8 163
Takahiro Ozutsumi Japan 8 122 1.7× 63 1.1× 48 1.4× 43 1.3× 53 2.9× 18 202

Countries citing papers authored by Kate D. Lynch

Since Specialization
Citations

This map shows the geographic impact of Kate D. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate D. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate D. Lynch more than expected).

Fields of papers citing papers by Kate D. Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate D. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate D. Lynch. The network helps show where Kate D. Lynch may publish in the future.

Co-authorship network of co-authors of Kate D. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Kate D. Lynch. A scholar is included among the top collaborators of Kate D. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate D. Lynch. Kate D. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghaly, Simon, et al.. (2025). Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas. Internal Medicine Journal. 55(3). 461–466. 1 indexed citations
2.
Su, Wen‐Yu, Wayne H. Wilson, Weng Ng, et al.. (2025). DOP106 Geographic disparities in Healthcare Utilisation in people with inflammatory bowel disease, Crohn’s Colitis Cure Data Insights Program. Journal of Crohn s and Colitis. 19(Supplement_1). i277–i278.
3.
Su, Wendy, William R. Wilson, Kate D. Lynch, et al.. (2025). P1281 Active perianal fistulising Crohn’s Disease is associated with a higher burden of psychological distress, depression, anxiety, stress and opioid use. Journal of Crohn s and Colitis. 19(Supplement_1). i2311–i2312. 1 indexed citations
4.
Lynch, Kate D., Nicholas Hannah, Avik Majumdar, et al.. (2025). Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective. Alimentary Pharmacology & Therapeutics. 61(10). 1612–1621.
5.
Lynch, Kate D., et al.. (2024). Mortality in Acute Severe Ulcerative Colitis - Still an Alarming and Real Complication in the Era of Advanced Therapies. The American Journal of Gastroenterology. 119(11). 2346–2346.
6.
Bryant, Robert G., Susan J. Connor, Anthony Croft, et al.. (2024). P854 Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. Journal of Crohn s and Colitis. 18(Supplement_1). i1573–i1573. 3 indexed citations
7.
Lynch, Kate D., et al.. (2024). Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitis. Expert Opinion on Pharmacotherapy. 25(13). 1835–1849.
8.
Mikocka‐Walus, Antonina, et al.. (2024). Psychological Care for People with Inflammatory Bowel Diseases: Exploring Consumers’ Perspectives to Inform Future Service Co-design. Digestive Diseases and Sciences. 69(6). 1979–1989. 1 indexed citations
9.
Fevery, Johan, Douglas G. Adler, Annika Bergquist, et al.. (2024). Determining the time to cholangiocarcinoma in pediatric‐onset PSC‐IBD. Journal of Pediatric Gastroenterology and Nutrition. 80(3). 450–454.
10.
Biondi, Mia J., Kate D. Lynch, Kirby Cronin, et al.. (2024). Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario. Journal of Obstetrics and Gynaecology Canada. 46(6). 102423–102423. 1 indexed citations
11.
McNamara, Judith, Wayne H. Wilson, Simon Ghaly, et al.. (2024). P286 Variation of outcomes in inflammatory bowel disease at ten Australasian centres - Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn s and Colitis. 18(Supplement_1). i650–i650.
12.
Read, Scott, Asma Baig, Kate Marshall, et al.. (2024). Efficacy of albumin use in decompensated cirrhosis and real‐world adoption in Australia. JGH Open. 8(9). e70029–e70029.
13.
Goess, Charlotte, et al.. (2023). P613 Switch from intravenous to subcutaneous maintenance infliximab in real world IBD cohort. Journal of Crohn s and Colitis. 17(Supplement_1). i741–i743. 2 indexed citations
14.
Bryant, Robert V., et al.. (2022). Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics. 57(1). 23–36. 8 indexed citations
15.
Bryant, Robert V., et al.. (2022). Attitudes towards COVID‐19 vaccination in patients with inflammatory bowel disease. Internal Medicine Journal. 52(6). 1070–1074. 4 indexed citations
16.
Barnes, Alex, Kate D. Lynch, Rachel Grafton, et al.. (2022). Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 68(3). 889–896. 3 indexed citations
17.
Lynch, Kate D., Fabiola Curion, Helen Ferry, et al.. (2019). Analysis of liver infiltrating lymphocytes in primary sclerosing cholangitis by surface antigen and single cell RNA sequencing using fine needle aspiration of the liver. Journal of Gastroenterology and Hepatology. 34. 46–47. 1 indexed citations
18.
Lynch, Kate D., Satish Keshav, & Roger W. Chapman. (2019). The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Current Hepatology Reports. 18(1). 115–126. 13 indexed citations
19.
Lynch, Kate D., Fabiola Curion, Hing‐Yuen Yeung, et al.. (2019). 762 – Analysis of Liver Infiltrating Lymphocytes in Primary Sclerosing Cholangitis by Surface Antigen and Single Cell Rnaseq. Gastroenterology. 156(6). S–1212. 1 indexed citations
20.
Lynch, Kate D., et al.. (2018). Anti-Gp210 and Anti-Sp100 Antibody Status andUrsodeoxycholic Acid Response in Primary Biliary Cholangitis. Journal of Gastroenterology and Hepatology Research. 7(6). 2741–2747. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Waleed Fateen Breakdown of academic impact, for papers by Stefan Lueth Breakdown of academic impact, for papers by Rika Iwata Breakdown of academic impact, for papers by Álvaro Giráldez Gallego Breakdown of academic impact, for papers by Kai‐Chi Chang Breakdown of academic impact, for papers by Martina Gagliardi Breakdown of academic impact, for papers by Chengxiao Yu Breakdown of academic impact, for papers by Michaela Neagu Breakdown of academic impact, for papers by Rebecca Saich Breakdown of academic impact, for papers by Takahiro Ozutsumi
Rankless by CCL
2026